Assertio (ASRT)

• Market cap: $58.2M
• 1 day: -1.41%
• 5 days: -9.48%
• 1 month: -22.48%
• 3 months: -31.34%
• 6 months: -5.72%
• Year to date: -28.86%
• 1 year: -30.6%
• 5 years: -57.74%
• 10 years: -99.17%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Employees: 30